AIMS: Luma is a recently discovered, evolutionarily conserved protein expressed in mammalian heart, which is associated with the LInker of Nucleoskeleton and Cytoskeleton (LINC) complex. The LINC complex structurally integrates the nucleus and the cytoplasm and plays a critical role in mechanotransduction across the nuclear envelope. Mutations in several LINC components in both humans and mice result in various cardiomyopathies, implying they play essential, non-redundant roles. A single amino acid substitution of serine 358 to leucine (S358L) in Luma is the unequivocal cause of a distinct form of arrhythmogenic cardiomyopathy. However, the role of Luma in heart has remained obscure. In addition, it also remains to be determined how the S358L mutation in Luma leads to cardiomyopathy. METHODS AND RESULTS: To determine the role of Luma in the heart, we first determined the expression pattern of Luma in mouse heart. Luma was sporadically expressed in cardiomyocytes throughout the heart, but was highly and uniformly expressed in cardiac fibroblasts and vascular smooth muscle cells. We also generated germline null Luma mice and discovered that germline null mutants were viable and exhibited normal cardiac function. Luma null mice also responded normally to pressure overload induced by transverse aortic constriction. In addition, localization and expression of other LINC complex components in both cardiac myocytes and fibroblasts was unaffected by global loss of Luma. Furthermore, we also generated and characterized Luma S358L knock-in mice, which displayed normal cardiac function and morphology. CONCLUSION: Our data suggest that Luma is dispensable for murine cardiac development and function and that the Luma S358L mutation alone may not cause cardiomyopathy in mice. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Luma is a recently discovered, evolutionarily conserved protein expressed in mammalian heart, which is associated with the LInker of Nucleoskeleton and Cytoskeleton (LINC) complex. The LINC complex structurally integrates the nucleus and the cytoplasm and plays a critical role in mechanotransduction across the nuclear envelope. Mutations in several LINC components in both humans and mice result in various cardiomyopathies, implying they play essential, non-redundant roles. A single amino acid substitution of serine 358 to leucine (S358L) in Luma is the unequivocal cause of a distinct form of arrhythmogenic cardiomyopathy. However, the role of Luma in heart has remained obscure. In addition, it also remains to be determined how the S358L mutation in Luma leads to cardiomyopathy. METHODS AND RESULTS: To determine the role of Luma in the heart, we first determined the expression pattern of Luma in mouse heart. Luma was sporadically expressed in cardiomyocytes throughout the heart, but was highly and uniformly expressed in cardiac fibroblasts and vascular smooth muscle cells. We also generated germline null Luma mice and discovered that germline null mutants were viable and exhibited normal cardiac function. Luma null mice also responded normally to pressure overload induced by transverse aortic constriction. In addition, localization and expression of other LINC complex components in both cardiac myocytes and fibroblasts was unaffected by global loss of Luma. Furthermore, we also generated and characterized Luma S358L knock-in mice, which displayed normal cardiac function and morphology. CONCLUSION: Our data suggest that Luma is dispensable for murine cardiac development and function and that the Luma S358L mutation alone may not cause cardiomyopathy in mice. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Farah Sheikh; Kunfu Ouyang; Stuart G Campbell; Robert C Lyon; Joyce Chuang; Dan Fitzsimons; Jared Tangney; Carlos G Hidalgo; Charles S Chung; Hongqiang Cheng; Nancy D Dalton; Yusu Gu; Hideko Kasahara; Majid Ghassemian; Jeffrey H Omens; Kirk L Peterson; Henk L Granzier; Richard L Moss; Andrew D McCulloch; Ju Chen Journal: J Clin Invest Date: 2012-03-19 Impact factor: 14.808
Authors: Xi Fang; Matthew J Stroud; Kunfu Ouyang; Li Fang; Jianlin Zhang; Nancy D Dalton; Yusu Gu; Tongbin Wu; Kirk L Peterson; Hsien-Da Huang; Ju Chen; Nanping Wang Journal: JCI Insight Date: 2016-10-06
Authors: Hendrik Milting; Bärbel Klauke; Alex Hoerby Christensen; Jörg Müsebeck; Volker Walhorn; Sören Grannemann; Tamara Münnich; Tomo Šarić; Torsten Bloch Rasmussen; Henrik Kjærulf Jensen; Jens Mogensen; Carolin Baecker; Elena Romaker; Kai Thorsten Laser; Edzard zu Knyphausen; Astrid Kassner; Jan Gummert; Daniel P Judge; Sean Connors; Kathy Hodgkinson; Terry-L Young; Paul A van der Zwaag; J Peter van Tintelen; Dario Anselmetti Journal: Eur Heart J Date: 2014-03-04 Impact factor: 29.983
Authors: Jerry S H Lee; Christopher M Hale; Porntula Panorchan; Shyam B Khatau; Jerry P George; Yiider Tseng; Colin L Stewart; Didier Hodzic; Denis Wirtz Journal: Biophys J Date: 2007-07-13 Impact factor: 4.033
Authors: Matthew J Stroud; Wei Feng; Jianlin Zhang; Jennifer Veevers; Xi Fang; Larry Gerace; Ju Chen Journal: J Cell Biol Date: 2017-05-22 Impact factor: 10.539
Authors: Matthew J Stroud; Alicja Nazgiewicz; Edward A McKenzie; Yisu Wang; Richard A Kammerer; Christoph Ballestrem Journal: J Cell Sci Date: 2014-04-04 Impact factor: 5.285
Authors: Yonatan R Lewis-Israeli; Brett D Volmert; Mitchell A Gabalski; Amanda R Huang; Aitor Aguirre Journal: J Vis Exp Date: 2021-09-15 Impact factor: 1.424
Authors: Astrid Brull; Blanca Morales Rodriguez; Gisèle Bonne; Antoine Muchir; Anne T Bertrand Journal: Front Physiol Date: 2018-10-30 Impact factor: 4.566